These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20451257)

  • 1. SIRT1 gene is associated with major depressive disorder in the Japanese population.
    Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Fukuo Y; Naitoh H; Umene-Nakano W; Inada T; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2010 Oct; 126(1-2):167-73. PubMed ID: 20451257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of SIGMAR1 with major depressive disorder and SSRI response.
    Kishi T; Yoshimura R; Okochi T; Fukuo Y; Kitajima T; Okumura T; Tsunoka T; Kawashima K; Yamanouchi Y; Kinoshita Y; Umene-Nakano W; Naitoh H; Nakamura J; Ozaki N; Iwata N
    Neuropharmacology; 2010 Jun; 58(7):1168-73. PubMed ID: 20178807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Tsunoka T; Ozaki N; Iwata N
    Neuromolecular Med; 2009; 11(2):53-7. PubMed ID: 19347611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.
    Kishi T; Ichinose H; Yoshimura R; Fukuo Y; Kitajima T; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Musso GM; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2012 Dec; 142(1-3):315-22. PubMed ID: 22770721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.
    Okuda A; Kishi T; Okochi T; Ikeda M; Kitajima T; Tsunoka T; Okumukura T; Fukuo Y; Kinoshita Y; Kawashima K; Yamanouchi Y; Inada T; Ozaki N; Iwata N
    Neuromolecular Med; 2010 Mar; 12(1):78-85. PubMed ID: 19760522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.
    Fukuo Y; Kishi T; Kushima I; Yoshimura R; Okochi T; Kitajima T; Matsunaga S; Kawashima K; Umene-Nakano W; Naitoh H; Inada T; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2011 Sep; 133(1-2):150-7. PubMed ID: 21663972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population.
    Kishi T; Fukuo Y; Yoshimura R; Okochi T; Kitajima T; Naitoh H; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
    Hum Psychopharmacol; 2010 Aug; 25(6):481-6. PubMed ID: 20737521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.
    Tsunoka T; Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):875-9. PubMed ID: 19386277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
    Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
    Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
    Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study.
    Kishi T; Fukuo Y; Kitajima T; Okochi T; Yamanouchi Y; Kinoshita Y; Kawashima K; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Ozaki N; Iwata N
    Genes Brain Behav; 2011 Apr; 10(3):257-63. PubMed ID: 20977650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients.
    Saito S; Takahashi N; Ishihara R; Ikeda M; Suzuki T; Kitajima T; Yamanouchi Y; Iwata N; Yamada M; Yoshida K; Inada T; Ozaki N
    Neuropsychobiology; 2006; 54(4):226-30. PubMed ID: 17356306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.
    Wang HC; Yeh TL; Chang HH; Gean PW; Chi MH; Yang YK; Lu RB; Chen PS
    Psychopharmacology (Berl); 2011 Feb; 213(4):773-9. PubMed ID: 20945066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder.
    Paroni G; Seripa D; Fontana A; D'Onofrio G; Gravina C; Urbano M; Addante F; Lozupone M; Copetti M; Pilotto A; Greco A; Panza F
    Mol Neurobiol; 2017 Mar; 54(2):1340-1351. PubMed ID: 26843110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between
    Xu Y; Ma H; Zhao T; Wen D; Wen Y; Qiao D; Liu Z
    Genet Test Mol Biomarkers; 2019 Dec; 23(12):843-849. PubMed ID: 31692380
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
    Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
    J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Tsunoka T; Inada T; Ozaki N; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):293-7. PubMed ID: 19224106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
    Illi A; Poutanen O; Setälä-Soikkeli E; Kampman O; Viikki M; Huhtala H; Mononen N; Haraldsson S; Koivisto PA; Leinonen E; Lehtimäki T
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):95-102. PubMed ID: 20640435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.